Summary & Overview
HCPCS Q4166: Cytal, per Square Centimeter (Add-on)
HCPCS Level II code Q4166 identifies Cytal billed per square centimeter as an add-on, list-separately product used in conjunction with a primary procedural service. As an add-on HCPCS Level II code, Q4166 is reported in addition to a primary surgical or procedural code when Cytal is applied, measured and billed by area. Nationally, material and product add-on codes matter for capturing total episode costs, ensuring supply-use transparency, and aligning billing with clinical documentation.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a focused overview of the code's clinical role, the typical sites of service where it is used, and the payer landscape covered. The publication also outlines common modifiers associated with reporting add-on supplies (listed separately) and highlights what to expect in benchmarks and policy context when available.
This summary provides operational clarity for revenue cycle, compliance, and clinical teams on how Q4166 is intended to be reported and where it fits in the service line. Data not available in the input will be noted where applicable in detailed sections.
Billing Code Overview
HCPCS Level II code Q4166 describes Cytal, billed per square centimeter as an add-on service that is reported separately in addition to a primary procedure. This code represents a product or material applied or used in conjunction with another primary surgical or procedural service.
-
Service type: Product/material application associated with a primary procedural service
-
Typical site of service: Operative suite or procedural setting where the primary procedure is performed (e.g., ambulatory surgery center, hospital operating room)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult or pediatric patient undergoing a dermatologic or reconstructive procedure in which an advanced bioengineered skin substitute product, billed as Q4166 (Cytal, per square centimeter), is applied as an add-on material to a surgical wound or graft bed. The setting is most commonly an outpatient dermatology clinic, ambulatory surgery center, wound care center, or hospital outpatient department where debridement or excision of nonhealing ulcers, traumatic wounds, or skin cancer defects has been performed.
The clinical workflow begins with pre-procedure evaluation and diagnosis (for example, nonhealing venous stasis ulcer or full-thickness skin defect after Mohs surgery). The primary physician or surgeon performs any necessary excision, debridement, or wound bed preparation and documents wound size in square centimeters and the rationale for a biologic matrix or epidermal/dermal substitute. The product Q4166 is supplied and measured per square centimeter and applied directly to the prepared wound; the primary procedure (for example, excision or grafting) is reported with its appropriate CPT code, and Q4166 is billed as an add-on HCPCS code, listed separately. Post-application wound care instructions and follow-up visits for dressing changes and assessment of graft/take or healing are documented. Typical documentation includes wound measurements, product lot number and quantity (cm2), who applied the product, and clinical indications supporting medical necessity.
Coding Specifications
| Modifier | Description | When to Use |
|---|